Moywela, Bb Girl .
HRN: 26-14-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2024
AMPICILLIN 500MG (VIAL)
11/14/2024
11/21/2024
IV
150mg
Q12h
Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes